查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933354

全球抗生物膜敷料市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Anti-biofilm Dressings Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 132 Pages | 商品交期: 請詢問到貨日

價格

抗生物膜敷料市場成長因子

預計2025年全球抗生物膜敷料市場規模將達10.2億美元，2026年成長至11.1億美元，最終在2034年達到21.6億美元，複合年增長率高達8.66%。北美地區憑藉其完善的醫療保健基礎設施、先進的傷口護理技術以及醫護人員對生物膜管理的高度重視，將在2025年佔62.82%的市場佔有率。抗生物膜敷料是一種專門的傷口護理產品，旨在利用抗菌劑、螯合劑、界面活性劑和酵素基技術來破壞生物膜（阻礙傷口癒合的微生物群落）。

市場動態

驅動因素：慢性傷口（包括糖尿病潰瘍、壓瘡、動脈潰瘍、手術傷口和燒傷）的日益普遍，推動了對生物膜防護敷料的需求。慢性傷口極易形成生物膜，這會延緩癒合並增加感染風險。例如，全球約有186億人患有糖尿病足潰瘍（JAMA，2023），這構成了一個龐大的患者群體，需要先進的傷口護理。此外，微創敷料和酵素性抗生物膜技術的創新正在改善傷口治療效果和患者復原。

限制因素：新興國家對生物膜預防方案的依從性較低，限制了市場滲透率。在這些地區，人們對先進傷口護理方法的認知度仍然較低，醫療專業人員可能沒有完全實施最佳實踐，這限制了專用敷料的使用。

機會：新型抗生物膜製劑和基於奈米技術的解決方案具有巨大的成長潛力。對奈米材料（例如銀和氧化鋅奈米顆粒）的研究已顯示出在破壞生物膜方面具有良好的前景。針對生物膜胞外聚合物 (EPS) 的酵素性敷料正逐漸成為傳統銀基和碘基敷料的高效替代品。

挑戰：含有銀、蜂蜜和碘的抗生物膜敷料價格昂貴，阻礙了其廣泛應用，尤其是在報銷有限的新興地區。例如，在英國，一片銀敷料的價格在 8 美元到 20 美元之間，這限制了價格敏感型市場對這些產品的取得。

市場趨勢

近期趨勢包括酵素性敷料（例如DNase、蛋白酶和disperdin B）的日益普及。這些敷料可增強抗菌劑的滲透性和療效，使其對抗藥性菌株有效。其特異性和生物相容性備受關注，臨床研究表明，多酶療法在治療燒傷創面中的銅綠假單胞菌生物膜方面特別有效（美國微生物學會，2023）。

市場區隔分析

依分子類型劃分：銀基敷料因其廣譜抗菌活性、加速癒合和提高患者舒適度而佔主導地位。蜂蜜敷料因其對生物膜的高抑制率和膜破壞率而位居第三。

依傷口類型劃分：慢性傷口佔比最大，這主要是由於壓瘡、糖尿病足潰瘍和靜脈潰瘍的發生率不斷上升。同時，燒傷等急性傷口的數量也在穩定增加。

依最終使用者劃分：由於需要住院治療的慢性傷口患者數量眾多，醫院仍是主要的最終使用者群體。隨著患者越來越尋求經濟有效的居家傷口管理方案，居家照護預計將快速成長。

區域展望

北美：預計2025年將達到3.4億美元，2026年將達到3.7億美元，北美是最大的市場，這得益於其先進的醫療設施和龐大的患者群體。

歐洲：第二大市場，這得益於各大公司廣泛的推廣活動和強大的品牌影響力。

亞太地區：受中國、印度和馬來西亞等國家可支配收入成長、意識提高以及研究舉措的推動，預計到2034年，亞太地區的複合年增長率將最高。

拉丁美洲、中東和非洲：由於人們對慢性傷口的認識不斷提高以及先進傷口護理產品的普及，預計這兩個地區將保持穩定增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家主要疾病盛行率（2025/2025）
  • 主要產業趨勢：併購、業務合作
  • 產品供應：抗生物膜塗層、主要參與者

第五章：全球抗生物膜敷料市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依分子分類
    • 銀
    • 碘
    • 蜂蜜
    • 其他
  • 市場分析、洞察與預測：依傷口類型分類
    • 慢性傷口
    • 急性傷口
  • 市場分析、洞察與預測：依最終用戶分類
    • 醫院
    • 傷口診所
    • 家庭醫療保健
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美抗生物膜塗料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲抗生物膜塗料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 其他歐洲國家

第八章 亞太地區抗生物膜塗料市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲抗生物膜塗層市場分析：洞察與預測（2021-2034）

第十章：中東與非洲抗生物膜塗層市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC) 國家
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司公司簡介
    • Coloplast A/S
    • Convatec Inc.
    • Molnlycke AB
    • Solventum
    • URGO MEDICAL
    • INTEGRA LIFESCIENCES
    • Cardinal Health
    • Medline Industries, LP.
    • Smith+Nephew
    • B. Braun SE
Product Code: FBI113716

Growth Factors of anti-biofilm dressings Market

The global anti-biofilm dressings market was valued at USD 1.02 billion in 2025 and is projected to grow to USD 1.11 billion in 2026, ultimately reaching USD 2.16 billion by 2034, at a robust CAGR of 8.66%. North America held the dominant market share of 62.82% in 2025, owing to the presence of established healthcare infrastructure, advanced wound care technologies, and high awareness of biofilm management among healthcare providers. Anti-biofilm dressings are specialized wound care products designed to disrupt biofilms-microbial communities that hinder wound healing-through the use of antimicrobial agents, chelating agents, surfactants, and enzyme-based technologies.

Market Dynamics

Drivers: The rising prevalence of chronic wounds, including diabetic ulcers, pressure ulcers, arterial ulcers, surgical wounds, and burns, is fueling demand for anti-biofilm dressings. Chronic wounds are highly prone to biofilm formation, which delays healing and increases the risk of infections. For example, diabetic foot ulcers affect approximately 18.6 billion people globally (JAMA, 2023), creating a substantial patient pool requiring advanced wound care. Additionally, innovations in minimally invasive dressings and enzyme-based anti-biofilm technologies are improving wound outcomes and patient recovery.

Restraints: Limited adherence to biofilm prevention protocols in emerging countries restricts market adoption. In these regions, awareness about advanced wound care practices is still low, and healthcare professionals may not fully implement best practices, limiting the use of specialized dressings.

Opportunities: Novel anti-biofilm agents and nanotechnology-based solutions offer significant growth potential. Research into nanomaterials, such as silver and zinc oxide nanoparticles, has shown promising results in biofilm disruption. Enzyme-based dressings, which target the extracellular polymeric substance (EPS) of biofilms, are emerging as highly effective alternatives to traditional silver or iodine-based dressings.

Challenges: High costs of anti-biofilm dressings, including silver, honey, and iodine variants, hinder widespread adoption, especially in emerging regions with limited reimbursement. For instance, the cost per silver dressing in the U.K. ranges from USD 8 to USD 20, making these products less accessible in price-sensitive markets.

Market Trends

Recent trends include increased adoption of enzyme-based dressings, such as DNase, protease, and dispersin B, which enhance antimicrobial penetration and effectiveness. These formulations are effective against antibiotic-resistant strains and are gaining traction due to their specificity and biocompatibility. Clinical studies indicate the combined-enzyme approach is particularly effective in treating Pseudomonas aeruginosa biofilms in burn wounds (American Society for Microbiology, 2023).

Segmentation Analysis

By Molecule: Silver-based dressings dominate due to broad-spectrum antimicrobial activity, faster healing, and improved patient comfort. Honey dressings rank third, benefiting from high biofilm inhibition and membrane disruption rates.

By Wound Type: Chronic wounds hold the largest share due to increasing cases of pressure ulcers, diabetic wounds, and venous ulcers, while acute wounds, such as burns, are growing steadily.

By End-User: Hospitals remain the primary end-user segment due to high inpatient admissions for chronic wound care. Home care settings are expected to grow rapidly as patients increasingly seek cost-effective wound management solutions at home.

Regional Outlook

North America: Valued at USD 0.34 billion in 2025 and projected to reach USD 0.37 billion in 2026, the region is the largest market due to advanced healthcare facilities and a strong patient base.

Europe: The second-largest market, supported by extensive promotional campaigns and strong brand presence among key players.

Asia Pacific: Anticipated to witness the highest CAGR by 2034, driven by rising disposable income, awareness, and research initiatives in countries such as China, India, and Malaysia.

Latin America & Middle East & Africa: Both regions are expected to grow steadily due to increased awareness of chronic wounds and adoption of advanced wound care products.

Competitive Landscape

Key players such as Convatec Inc., Molnlycke AB, Smith+Nephew, Coloplast A/S, Solventum, URGO MEDICAL, INTEGRA LIFESCIENCES, Cardinal Health, and B. Braun SE dominate the market. Strategic initiatives, including product launches, collaborations, and clinical studies, are critical for expanding market share. For example, in March 2025, Convatec showcased advanced anti-biofilm dressings at the European Wound Management Association (EWMA) conference, reinforcing its market presence.

Conclusion

The global anti-biofilm dressings market is set for significant growth, increasing from USD 1.02 billion in 2025 to USD 1.11 billion in 2026 and reaching USD 2.16 billion by 2034 at a CAGR of 8.66%. Market expansion is driven by rising chronic wound prevalence, innovations in anti-biofilm technologies, enzyme-based dressings, and increased home care adoption. While high costs and limited awareness in emerging regions pose challenges, research, nanotechnology, and strategic collaborations by key players are anticipated to further strengthen the market. North America remains the dominant region, whereas Asia Pacific is emerging as the fastest-growing market due to rising awareness, disposable income, and technological advancements in wound care.

Segmentation By Molecule

  • Silver
  • Iodine
  • Honey
  • Others

By Wound Type

  • Chronic Wounds
  • Acute Wounds

By End-user

  • Hospitals
  • Wound Clinics
  • Home Care Settings
  • Others

By Geography

  • North America (By Molecule, Wound Type, End-user, and Country/Sub-region)
    • U.S.
    • Canada
  • Europe (By Molecule, Wound Type, End-user, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific (By Molecule, Wound Type, End-user, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Molecule, Wound Type, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Molecule, Wound Type, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, Key Countries, 2025/2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.3. Detailed Product Offerings: Anti-biofilm Dressings, Key Players

5. Global Anti-biofilm Dressings Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Molecule
    • 5.1.1. Silver
    • 5.1.2. Iodine
    • 5.1.3. Honey
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Wound Type
    • 5.2.1. Chronic Wounds
    • 5.2.2. Acute Wounds
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals
    • 5.3.2. Wound Clinics
    • 5.3.3. Home Care Settings
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Anti-biofilm Dressings Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Molecule
    • 6.1.1. Silver
    • 6.1.2. Iodine
    • 6.1.3. Honey
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Wound Type
    • 6.2.1. Chronic Wounds
    • 6.2.2. Acute Wounds
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals
    • 6.3.2. Wound Clinics
    • 6.3.3. Home Care Settings
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Anti-biofilm Dressings Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Molecule
    • 7.1.1. Silver
    • 7.1.2. Iodine
    • 7.1.3. Honey
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Wound Type
    • 7.2.1. Chronic Wounds
    • 7.2.2. Acute Wounds
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals
    • 7.3.2. Wound Clinics
    • 7.3.3. Home Care Settings
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Russia
    • 7.4.7. Rest of Europe

8. Asia Pacific Anti-biofilm Dressings Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Molecule
    • 8.1.1. Silver
    • 8.1.2. Iodine
    • 8.1.3. Honey
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Wound Type
    • 8.2.1. Chronic Wounds
    • 8.2.2. Acute Wounds
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals
    • 8.3.2. Wound Clinics
    • 8.3.3. Home Care Settings
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Anti-biofilm Dressings Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Service Type
  • 9.2. Market Analysis, Insights and Forecast - By Molecule
    • 9.2.1. Silver
    • 9.2.2. Iodine
    • 9.2.3. Honey
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Wound Type
    • 9.3.1. Chronic Wounds
    • 9.3.2. Acute Wounds
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Wound Clinics
    • 9.4.3. Home Care Settings
    • 9.4.4. Others
    • 9.4.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.6. Brazil
    • 9.4.7. Mexico
    • 9.4.8. Rest of Latin America

10. Middle East & Africa Anti-biofilm Dressings Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Molecule
    • 10.1.1. Silver
    • 10.1.2. Iodine
    • 10.1.3. Honey
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Wound Type
    • 10.2.1. Chronic Wounds
    • 10.2.2. Acute Wounds
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals
    • 10.3.2. Wound Clinics
    • 10.3.3. Home Care Settings
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Coloplast A/S
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Convatec Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Molnlycke AB
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Solventum
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. URGO MEDICAL
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. INTEGRA LIFESCIENCES
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Cardinal Health
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medline Industries, LP.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Smith+Nephew
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. B. Braun SE
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Molecule, 2021-2034
  • Table 2: Global Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Wound Type, 2021-2034
  • Table 3: Global Anti-biofilm Dressings Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Molecule, 2021-2034
  • Table 6: North America Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Wound Type, 2021-2034
  • Table 7: North America Anti-biofilm Dressings Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Anti-biofilm Dressings Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Molecule, 2021-2034
  • Table 10: Europe Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Wound Type, 2021-2034
  • Table 11: Europe Anti-biofilm Dressings Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Anti-biofilm Dressings Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Molecule, 2021-2034
  • Table 14: Asia Pacific Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Wound Type, 2021-2034
  • Table 15: Asia Pacific Anti-biofilm Dressings Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Anti-biofilm Dressings Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Molecule, 2021-2034
  • Table 18: Latin America Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Wound Type, 2021-2034
  • Table 19: Latin America Anti-biofilm Dressings Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Anti-biofilm Dressings Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Molecule, 2021-2034
  • Table 22: Middle East & Africa Anti-biofilm Dressings Market Revenue (USD million) Forecast, by Wound Type, 2021-2034
  • Table 23: Middle East & Africa Anti-biofilm Dressings Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Anti-biofilm Dressings Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Anti-biofilm Dressings Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Anti-biofilm Dressings Market Value Share (%), by Molecule, 2025 & 2034
  • Figure 3: Global Anti-biofilm Dressings Market Value Share (%), by Wound Type, 2025 & 2034
  • Figure 4: Global Anti-biofilm Dressings Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Anti-biofilm Dressings Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Anti-biofilm Dressings Market Value (USD million), by Molecule, 2025 & 2034
  • Figure 7: North America Anti-biofilm Dressings Market Value Share (%), by Molecule, 2025
  • Figure 8: North America Anti-biofilm Dressings Market Value (USD million), by Wound Type, 2025 & 2034
  • Figure 9: North America Anti-biofilm Dressings Market Value Share (%), by Wound Type, 2025
  • Figure 10: North America Anti-biofilm Dressings Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Anti-biofilm Dressings Market Value Share (%), by End-user, 2025
  • Figure 12: North America Anti-biofilm Dressings Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Anti-biofilm Dressings Market Value Share (%), By Country, 2025
  • Figure 14: Europe Anti-biofilm Dressings Market Value (USD million), by Molecule, 2025 & 2034
  • Figure 15: Europe Anti-biofilm Dressings Market Value Share (%), by Molecule, 2025
  • Figure 16: Europe Anti-biofilm Dressings Market Value (USD million), by Wound Type, 2025 & 2034
  • Figure 17: Europe Anti-biofilm Dressings Market Value Share (%), by Wound Type, 2025
  • Figure 18: Europe Anti-biofilm Dressings Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Anti-biofilm Dressings Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Anti-biofilm Dressings Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 21: Europe Anti-biofilm Dressings Market Value Share (%), By Country/Sub-region, 2025
  • Figure 22: Asia Pacific Anti-biofilm Dressings Market Value (USD million), by Molecule, 2025 & 2034
  • Figure 23: Asia Pacific Anti-biofilm Dressings Market Value Share (%), by Molecule, 2025
  • Figure 24: Asia Pacific Anti-biofilm Dressings Market Value (USD million), by Wound Type, 2025 & 2034
  • Figure 25: Asia Pacific Anti-biofilm Dressings Market Value Share (%), by Wound Type, 2025
  • Figure 26: Asia Pacific Anti-biofilm Dressings Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Anti-biofilm Dressings Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Anti-biofilm Dressings Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Anti-biofilm Dressings Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Anti-biofilm Dressings Market Value (USD million), by Molecule, 2025 & 2034
  • Figure 31: Latin America Anti-biofilm Dressings Market Value Share (%), by Molecule, 2025
  • Figure 32: Latin America Anti-biofilm Dressings Market Value (USD million), by Wound Type, 2025 & 2034
  • Figure 33: Latin America Anti-biofilm Dressings Market Value Share (%), by Wound Type, 2025
  • Figure 34: Latin America Anti-biofilm Dressings Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Latin America Anti-biofilm Dressings Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Anti-biofilm Dressings Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Anti-biofilm Dressings Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Anti-biofilm Dressings Market Value (USD million), by Molecule, 2025 & 2034
  • Figure 39: Middle East & Africa Anti-biofilm Dressings Market Value Share (%), by Molecule, 2025
  • Figure 40: Middle East & Africa Anti-biofilm Dressings Market Value (USD million), by Wound Type, 2025 & 2034
  • Figure 41: Middle East & Africa Anti-biofilm Dressings Market Value Share (%), by Wound Type, 2025
  • Figure 42: Middle East & Africa Anti-biofilm Dressings Market Value (USD million), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Anti-biofilm Dressings Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Anti-biofilm Dressings Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Anti-biofilm Dressings Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Anti-biofilm Dressings Market Share (%), By Company, 2025